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 ABSTRACT 
Patients with bicuspid aortic valve (BAV) have an increased risk of developing 
ascending aortic aneurysm compared with individuals with a tricuspid aortic valve 
(TAV). A crucial factor involved in vascular remodeling during aneurysm development 
is transforming growth factor-β (TGF-β) and impaired signaling of this pathway can 
alter important extracellular matrix (ECM) protein such us fibronectin and collagen 
and thereby explaining the increased aneurysm susceptibility of BAV patients. The 
overall aim of this thesis was to investigate the BAV-associated aortopathy in relation 
to the TGF-β signaling pathway. 
Alternatively spliced extra domain A (EDA) of fibronectin (FN) has an essential role 
in tissue repair. In paper I, the mRNA expression of FN splice forms was analyzed by 
Affymetrix Exon arrays in dilated and non-dilated ascending aorta of TAV (40 
individuals) and BAV patients (69 individuals). EDA-FN was significantly increased only 
in TAV dilated aortas. Upon TGF-β treatment, vascular smooth muscle cells (vSMCs) 
isolated from TAV aortas were able to enhance the formation of EDA-FN whereas cells 
derived from BAV patients could not influence fibronectin splicing. Multivariate and 
univariate data analyses of mRNA expression suggested that differences in the TGF-β 
signaling pathway may explain the impaired EDA inclusion in BAV patients. 
In paper II, multivariate techniques were applied to all exons (n = 614) of the TGF-β 
pathway in order to analyze alternative splicing in the TGF-β pathway. Alternative 
splicing mechanisms were found to be important in the development of aneurysm in 
both BAV and TAV patients. Furthermore, the pattern of alternative splicing is clearly 
different between TAV and BAV patients. Differential splicing was specific for BAV and 
TAV patients in 40 and 86 exons, respectively, and splicing of 61 exons were shared 
between the two phenotypes. This suggested that dilatation in TAV and BAV patients 
has different alternative splicing fingerprints in the TGF-β pathway. 
In paper III, collagen homeostasis in non-dilated and dilated aortas of BAV patients 
was studied and compared to non-dilated and dilated aortas taken from tricuspid 
aortic valve patients as reference. Ascending aortas from 56 patients were used for 
biochemical and morphological analyses of collagen. Collagen turnover rates were 
similar in non-dilated and dilated aortas of BAV patients, showing that aneurysm 
formation in BAV is, in contrast to TAV, not associated with an increased collagen 
turnover. In addition, the ratio of hydroxylysyl pyridinoline (HP) to lysyl pyridinoline 
(LP), two distinct forms of collagen cross-linking, was lower in dilated aortas from 
patients with BAV, which hints at a defect in the posttranslational collagen 
modification associated with BAV.  
In paper IV, the response to TGF-β was analyzed in primary aortic smooth muscle 
cells isolated from 7 BAV and 5 BAV patients and 217 genes were found differentially 
expressed following TGF-β1 treatment in BAV vSMCs, whereas no gene was 
significantly altered between treated/untreated vSMCs of TAV patients. Majority of 
genes were down-regulated and enriched in genes involved in angiogenesis and 
formation of focal adhesion. Importantly, principle component analysis based on the 
217 genes demonstrated that there was a clear difference in expression of these 
genes in intima/media region of dilated ascending aorta of BAV and TAV patients.  
In conclusion, the understanding of impairments in the TGF-β signaling pathway 
could be the key to unravel the molecular mechanisms underlying BAV-associated 
aortopathy. 
POPULÄRVETENSKAPLIG SAMMANFATTNING 
Aortaklaffen är den klaff som sitter mellan hjärtats vänstra kammare och stora 
kroppspulsådern (aorta), och som förhindrar att blod rinner tillbaka till kammaren då 
hjärtat slappnar av. Vanligtvis består aortaklaffen av tre delar (kuspar), men hos ca 1-2 
procent av befolkningen förekommer en missbildning där två av kusparna 
sammansmält och bildat en tvådelad, så kallad bikuspid aortaklaff (BAV). Patienter 
med BAV drabbas i högre utsträckning av både klaff- och aortakomplikationer, så som 
stenotisk/läckande klaff och pulsåderbråck (aneurysm) än patienter med tredelad 
(trikuspid) aortaklaff (TAV).   
Transforming growth factor β (TGFβ) är ett protein som finns i kärlväggen och 
förändringar i TGFβ aktivitet har föreslagits påverka uppkomst av aneurysm. Bland 
annat reglerar TGFβ celltillväxt, celldöd och omsättningen av flera viktiga 
komponenter i kärlväggen så som t.ex. kollagen och fibronektin. En defekt reglering av 
TGFβ-signalering kan således leda till en förändrad sammansättning av kärlväggen 
med en ökad risk för utveckling av aneurysm som följd. Det övergripande syftet med 
den här avhandlingen var att studera TGFβ i relation till aneurysmutveckling hos 
patienter med BAV och TAV.  
I delarbete I studerades uttrycket av EDA-fibronektin, en speciell variant av 
fibronektin som spelar en särskild roll i vävnadsreparation. Ett ökat uttryck av EDA-
fibronektin kunde ses i vävnadsbitar från TAV-patienter med dilaterad aorta (vidgad) 
jämfört med TAV-patienter med icke-dilaterad aorta. Ingen skillnad i uttryck kunde 
dock ses mellan dilaterad och icke-dilaterad aorta från BAV-patienter. Behandling med 
TGFβ visades öka bildande av EDA-fibronektin i glattmuskelceller isolerade från TAV-, 
men inte BAV-patienter. En defekt TGFβ-signalering hos patienter med BAV skulle 
kunna förklara det lägre uttrycket av EDA-fibronektin i aorta hos dessa patienter, 
vilket i sin tur kan bidra till en försämrad vävnadsreparation.   
I delarbete II kunde vi visa att det finns en tydlig skillnad i alternativ splicing av 
gener relaterade till TGFβ-signalering hos patienter med BAV och TAV. Alternativ 
splicing är en viktig regleringsmekanism som innebär att flera proteinprodukter, med 
potentiellt olika funktionalitet, kan bildas från samma gen. Mönstret av alternativ 
splicing skilde sig tydligt åt mellan de olika patientgrupperna, vilket tyder på att gener 
involverade i TGFβ-signalering regleras olika hos patienter med BAV respektive TAV.  
I delarbete III studerades omsättning och uppbyggnad av kollagen, en strukturellt 
och funktionellt viktig komponent av kärlväggen som bidrar till aortans stabilitet. Hos 
patienter med TAV kunde en ökad omsättning av kollagen ses i dilaterad vävnad 
jämfört med icke-dilaterad vävnad. En sådan ökning kunde däremot inte ses hos BAV-
patienter. Vidare kunde en minskad kross-linking, dvs. svagare sammansättning, av 
kollagenet i vävnad isolerad från dilaterad aorta ses hos patienter med BAV. En 
försvagad sammansättning tyder på en defekt modifiering och reglering av denna 
viktiga kärlväggskomponent hos patienter med BAV.  
I delarbete IV studerades hur odlade glattmuskelceller, isolerade från aorta från 
respektive patientgrupp, svarar på TGFβ-behandling. Till skillnad från celler isolerade 
från TAV-patienter, kunde en stor skillnad ses i genuttryck efter TGFβ-behandling hos 
BAV-patienter. De flesta generna som skilde sig i uttryck var nedreglerade, och 
majoriteten var kopplade till nybildning av blodkärl och bildandet av stora 
proteinkomplex, så kallade focal adhesions som cellen använder sig av för att ankra till 
 
kringliggande vävnad. En nedreglering av dessa gener skulle kunna bidra till en ökad 
aneurysmrisk genom att göra kärlväggen svagare.  
Sammanfattningsvis visar resultat från den här avhandlingen på en defekt reglering 
av TGFβ-signalvägen hos patienter med BAV. Detta skulle kunna förklara den ökade 
risken för utveckling av aneurysm hos patienter med BAV. 
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 1 INTRODUCTION 
 
1.1 THORACIC AORTIC ANEURYSM (TAA) 
 
The term “aneurysm” was probably mentioned for the first time by the Greek 
physician Rufus of Ephesus in the late 1st century AD, and it semantically derives from 
ana (on top of, towards the outside) and eurunô (widening). Galen, shortly after 
Rufus, uses the term aneurysms for arterial dilatations occurring after a trauma, 
describing it as “when the skin above has formed a scar, and the wound to the artery 
has remained unhealed”. It was only later in the 16th century that, aneurysms in aorta 
and other arteries were recognized as a common pathology, with Jean Fernel, at 
Sorbonne, being the first to report on the aneurysms of internal arteries [1]. Today, 
aneurysms are defined as a persistent localized enlargement of vessels, exceeding 
50% of the expected diameter.  
Virtually every vascular entity can become aneurysmal, with the aorta being the 
most common location for aneurysm development in humans [2]. The most common 
location for aortic aneurysms is the infra-renal abdominal aorta (Abdominal Aortic 
Aneurysms (AAAs)), followed by thoracic aneurysms in the ascending aorta (Thoracic 
Aortic Aneurysms (TAAs)) (Figure 1).  
 
 
Figure 1. The two most common locations of thoracic aortic aneurysm  
(from www.merckmanuals.com) 
 
TAAs and AAAs share some pathological phenotypes, including the loss of vascular 
smooth muscle cells (vSMCs) and destruction of matrix elastic fibers, but, in addition 
to different locations, they differ in various physiological and etiological attributes and 
therefore are considered as two separate diseases [3]. 
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AAAs are almost always due to atheroma associated with identifiable risk factors 
(i.e. male sex, hypertension and smoking) generally occurring in old age, often in the 
absence of history and primarily associated with atherosclerosis and inflammation [4]. 
In contrast, TAAs are usually not related to atheromas and often occur at a younger 
age with a strong genetic component involved in the etiology. At the molecular level, 
TAAs are defined by medial degeneration, traditionally termed cystic medial necrosis, 
a poorly understood mechanism characterized by loss of smooth muscle cells, 
fragmented and diminished number of elastic fibers, and increased accumulation of 
proteoglycans [5]. TAAs can involve the aortic root, ascending aorta, arch, descending 
aorta, or a combination of all these locations. The combination of aortic root dilatation 
and ascending aneurysm is termed “annuloaortic ectasia.” 
 
1.1.1 Thoracic Aortic Dissection 
Aortic aneurysm is a costly disease in terms of both human lives and medical 
expenditure since it expands asymptomatically until a catastrophic event such as 
aortic rupture or dissection, signals the disease.  
Dissection occurs when a tear in the inner wall of the aorta causes blood to flow 
between the layers of the wall of the aorta, forcing the layers apart. The risk factors 
for aortic dissection include the presence of a pre-existing dilatation, hypertension 
and hardening of the aortic wall due to atherosclerosis, aortic valve defects and 
congenital narrowing of the aorta (coarctation) [6]. 
Like aortic aneurysms, aortic dissections are categorized based on the 
location/extent of the dissection and are more frequently occurring in association 
with TAA (Figure 2). Type A dissection is the most common and dangerous type of 
aortic dissection, demanding prompt surgical treatment. It originates in the ascending 
aorta, just where it rises out from the heart. At this point, there is no support from 
nearby structures and the pressure is the highest on the aortic wall. Type B dissections 
involve the descending aorta and can usually be controlled by blood pressure 
treatments and regular monitoring. 
 
 
Figure 2. Ascending TAA (left) and type A dissection (right) 
(from www.sphcs.org - www.radpod.org) 
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Individuals with certain genetic diseases, affecting the integrity of aortic wall, run 
higher risks of having aortic dissection than general population. These heritable 
disorders include Marfan syndrome (MFS), vascular Ehlers–Danlos syndrome, familial 
forms of TAAs or aortic dissection and will be further discussed in the next paragraph 
[7]. 
 
1.2 CLASSIFICATION OF TAAs 
 
A variety of pathological conditions may give rise to TAA (inherited syndromes, 
congenital conditions, hypertension, atherosclerosis, infections) according to which, 
TAAs can be classified into different groups of idiopathic/sporadic, syndromic, familial 
and bicuspid aortic valve-associated. 
 
 Idiopathic/sporadic forms of TAAs 
Most TAAs are classified as idiopathic/sporadic, occurring in individuals 
without familial transmission. The pathogenesis of those aneurysms, which is 
due to non-inflammatory processes such as hypertension, is often associated 
with medial degeneration of the elastic aortic walls. An approximately 2:1 
male predilection for non-inflammatory TAA exists. Of note, atherosclerosis 
which provides the inflammatory component to some cases of thoracic 
aneurysms, accounts for only 1% of ascending TAAs while it is associated in 
90% of the cases with descending TAAs [8].  
Infections are rare causes of sporadic inflammatory-type TAAs. Syphilitic 
aneurysms result in marked aortic root dilatation with ascending aneurysms 
but are extremely rare in industrialized countries, accounting for less than 1% 
of TAAs [9]. Other rare infectious bacterial aneurysms, termed mycotic 
aneurysms, [10] occur mostly in the descending aorta and are the 
consequence of bacteremia in patients with a history of infectious 
endocarditis. 
 
 Syndromic TAA  
MFS is the most common inherited form of syndromic TAAs and is a multi-
systemic disorder in which aneurysms occur in association with a wide range 
of other clinical abnormalities (eyes, skeleton, and cardiovascular system). MFS 
results from mutations in the fibrillin 1 gene located on chromosome 
15q15-31. Since the first mutation was described in 1991 [11], more than 
1,000 different (mostly missense) mutations in this gene have been identified. 
Recently mutations in the SMAD3 gene have also been identified in families 
with familial forms of TAA [12]. This TAA is termed Marfan-like syndrome for 
the skeletal features similarities shared with MFS. 
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Loeys-Dietz syndrome is an autosomal dominant connective tissue disorder 
that is a rare cause of TAA. It results from genetic mutations in the 
transforming growth factor beta receptors 1 and 2 (TGFBR1 and TGFBR2) [13].  
Vascular Ehlers–Danlos syndrome (type IV) is an autosomal dominant 
disorder that also manifests arterial aneurysms, rupture and dissection, as well 
as thin, translucent skin and easy bruising. It results from mutations in the 
COL3A1 gene (a type III collagen) [14] which determine extreme friability and 
fragility of the aortic tissue.  
 
 Familial non syndromic TAA 
This group comprehends the familial TAAs and dissections in which 
aneurysms/dissection occur in absence of other clinical manifestations and 
typically follow an autosomal dominant pattern of inheritance. Six different 
genetic loci have been recognized in families with familial non-syndromic 
TAAs, but only three genes have been identified: TGFBR2 in TAA2, ACTA2 in 
TAA4 and MYH11 in familial TAA and patent ductus arteriosus [5, 15].  
 
 
1.2.1 Bicuspid aortic valve-associated TAA 
An important number of non-inflammatory aneurysms are associated with congenital 
condition due to the presence of a bicuspid aortic valve (BAV), a topic that will be 
further discussed in the next paragraph. BAV can be highly heritable [16] as well as a 
sporadic event with low penetrance and its association with TAA is poorly understood. 
Therefore, BAV-associated aneurysm requires a special classification among the TAAs.  
  
The age of disease manifestation is largely affected by different TAA etiologies and 
three different clinical populations can be identified within the group of patients with 
TAA, as illustrated in figure 3 [17, 18]. Patients with inherited disorders (also called 
monogenic TAAs) have an early disease onset at childhood or adolescence and require 
surgery very early in their life. Patients with idiopathic aneurysms (also referred as to a 
degenerative pathology) are the oldest at the time of undergoing surgery and patients 
with BAV are somewhere in between the monogenic and the idiopathic TAAs. 
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     Figure 3. Age at surgery of different types of TAAs patients. Permission obtained from [18]. 
 
 
 
1.3 BICUSPID AORTIC VALVE (BAV) AND TAA 
 
A bicuspid aortic valve is an aortic valve that only has two leaflets (cusps), instead of 
three (Figure 4). BAV has been recognized as a common congenital abnormality for 
centuries and was firstly described by Leonardo da Vinci [19]. BAV results from 
abnormal aortic cusp formation during valvulogenesis, where adjacent cusps fuse to 
form a single aberrant cusp, larger than its counterpart yet smaller than 2 normal 
cusps combined.  
 
 
Figure 4. Schematic representation of normal TAV and BAV 
(from www.scripps.org) 
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BAV is often referred to as a syndrome since in addition to the valve abnormalities can 
be accompanied by various left heart lesions such as hypoplastic left heart, arch 
hypoplasia and aortic coarctation [20]. In adulthood, complications are common: the 
presence of a BAV represents a high likelihood of requiring interventions on the aortic 
valve and/or aorta which makes the burden of diseases associated with BAV more 
significant than any other congenital cardiac defect [21].  
Aortic stenosis (AS) is the most frequent complication of BAV, consisting of calcium 
deposits on the leaflets with consequent hardening and stiffness of the valve, a 
condition that in many cases requires aortic valve replacement (Figure 5 b).  
Aortic regurgitation/insufficiency can also occur in the presence of a BAV, caused 
by cusp prolapse, fibrotic retraction, or dilation of the sinotubular junction (Figure 5 c).  
 
 
 
Figure 5. Normal TAV (a). Diseased stenotic BAV (b) and diseased regurgitant BAV (c) 
(from www.heart-valve-surgery.com - www.quizlet.com - www.docstoc.com) 
 
 
As mentioned above, there is a significant clinical association between TAA and BAV. 
BAV is the most common cardiovascular malformation which affects approximately 1-
2% of the general population with a male predominance of approximately 2:1 [22-25]. 
TAAs affect about 50% of patients with BAVs and are associated with increased risk of 
dissection and rupture [23, 26, 27]. 
The commonly observed phenotypes of aneurysm associated with BAV disease are 
shown in figure 6. The most common type is a supracoronary enlargement with 
preservation of the sinotubular junction (type 1). The next most common 
demonstrates ectasia of the ascending aorta and root with loss of the sinotubular 
junction (type 2). The least common is similar in appearance to the aneurysm typical 
of MFS and is confined to the root itself (type 3) [28].  
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Figure 6: Types of ascending aortic aneurysms. Permission obtained from [28]. 
 
 
The autosomal dominant inheritance of BAV (Online Mendelian Inheritance in Man 
#109730, www.omim.org) in some families is well-documented; however, the 
inheritance of BAV with TAA is less clear. Two major hypotheses describing the 
increased prevalence of ascending aortic dilatation, rupture, and dissection in patients 
with BAV have been proposed [29].  
The first is that a genetic or developmental abnormality present in patients with 
BAV decreases aortic wall strength and predisposes it to complications [30]. Family-
based studies suggest that BAV-TAA syndrome follows an autosomal dominant 
pattern of inheritance in their families [31]. Moreover, the strongest genetic link 
found in human so far seems to be mutations in the NOTCH1 gene in a subset of 
patients with combined BAV-TAA [32]. However, more recently, with the 
development of more advanced measurement techniques, the contribution of 
hemodynamic factors to the development of aneurysm in BAV has also gained further 
ground. The second theory relies on the higher blood velocity and eccentric flow jets 
caused by a BAV which can lead to increased shear stress on the ascending aortic wall 
and thereby increasing the risk of ascending aortic dilatation, dissection, and rupture 
[33].  
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1.4 HEART VALVE FORMATION: A SOURCE FOR UNDERSTANDING THE 
PATHOGENESIS OF BAV CONGENITAL MALFORMATION 
 
Heart valves formation is a coordinated process in which growth factor signaling and 
extracellular matrix proteins meticulously orchestrate the migration of specific 
primordial cells that will constitute the heart valves, an event occurring 
simultaneously to the heart chambers formation (Figure 7). The developing heart tube 
contains an outer layer of myocardium and an inner lining of endothelial cells 
separated by an ECM referred to as the cardiac jelly. The formation of the cardiac jelly, 
a gelatinous substance present between the endothelium and myocardium of the 
embryonic heart, starts in the middle of the third week after conception in humans 
and is thought to be stimulated by bone morphogenetic protein-4 (BMP4) [34]. 
During heart valve formation, a subset of endothelial cells overlying the future 
valve site are specified to delaminate, differentiate, and migrate into the cardiac jelly, 
a process referred to as endothelial-mesenchymal transition or transdifferentiation 
(EndMT). This is followed by a process of localized swellings of both cardiac jelly and 
mesenchymal cells which will eventually result into the formation of cardiac cushions, 
the primordial structures of the valves (Figure 8). Cardiac cushions undergo extensive 
remodeling from bulbous swellings to eventual thinly tapered heart valves [35].  
 
 
Figure 7. Development of the embryonic heart from 17 days after conception to 37 days 
(from www.bionalogy.com) 
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Figure 8. Valvulogenesis. Permission obtained from [35]. 
 
 
The human embryonic heart starts to contract at 65 beats per minute at the beginning 
of the fourth week which a few days later turn into a unidirectional flow [36]. 
Although cardiac contraction and EndMT start at the same time, the contribution of 
haemodynamics and growth factors to valvulogenesis at this stage remains unknown 
and shear forces might be relevant for fine-tuning morphogenesis [37]. 
Both the formation of cardiac jelly and EndMT process require the constant 
molecular regulation of different signaling pathways. The coordinated interaction of 
Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor beta (TGF-β), 
BMP, NOTCH, hyaluronan and Wnt/β-catenin pathways results in a proper 
mesenchymal invasion into the cardiac jelly [38]. The signaling pathway responsible 
for the initiation of EndMT is the BMP/ TGF-β pathway [35, 39].  
Endothelial cells receive the myocardial signal and are activated to secrete TGF-β as 
a latent complex. Activated endothelial TGF-β triggers the initial phenotypic changes 
of EndMT in an autocrine fashion. Myocardial BMP acts synergistically with 
endothelial TGF-β to enhance the TGF-β induced mesenchyme formation. 
Heart valve development is characterized by increasing complexity and 
organization of the extracellular matrix (ECM). Before EndMT, the ECM of endocardial 
cushions is rich in hyaluronan. After EndMT, the mesenchymal cells in the cushions, 
express a network of collagens and metalloproteinases to promote cell migration [40]. 
During late gestation and soon after birth, the valve leaflets become stratified into 
highly organized collagen, proteoglycan, and elastin-rich compartments. Given the 
important role of ECM in the formation and maturation of the valves, it is not 
surprising that abnormal expression and distribution of ECM proteins in the valves 
could give rise to developmental abnormalities such as BAV condition. 
The pathogenesis of congenital BAV malformations is still unknown. Some 
investigators have suggested that environmental factors such as impaired blood flow 
during valvulogenesis may be responsible for the incorrect fusion of cusps [19]. Others 
have argued that BAV can have a genetic cause, supported by high association of BAV 
with congenital abnormalities of the aorta (coarctation of the aorta and patent ductus 
arteriosis) [41]. Interestingly, bicuspid aortic valves are also found in combination with 
9 
other genetic disorders including Turner's syndrome. Approximately 35% of patients 
with Turner's syndrome and up to 80% of patients with coarctation of the aorta have 
an associated BAV although the significance of these associations is unclear [42].  
 
 
1.5 TGF-Β AND TAA FORMATION 
 
TGF-β family members have critical and specific roles during embryogenesis, such as 
the heart valve formation, and in maintaining the homeostasis state of adult tissues. 
Perturbations in their signaling pathways have been linked to a diverse set of 
developmental disorders and diseases, including cancer, fibrosis, autoimmune and 
cardiovascular diseases [43].  
TGF-β superfamily includes TGF-βs, BMPs and the activins/inhibins. All TGF-β family 
ligands are generated as dimeric precursor proteins and are subsequently cleaved by 
proteases before secretion. The cellular signal is elicited by binding of the ligand to a 
complex of type II and type I serine/threonine kinase transmembrane receptors. Each 
member of the TGF-β superfamily binds to a characteristic combination of type I and 
type II receptors.  
In case of TGF-β1, the most extensively studied member of the superfamily, a 25 
kDa homodimeric peptide is formed and, upon interaction with the receptor complex, 
initiates an intracellular signaling termed canonical pathway. This involves SMAD2 and 
SMAD3, which heterodimerize with the common-mediator SMAD4. The complex is 
then translocated to the nucleus, where it binds directly or in complex with other 
transcription factors to DNA and regulates the expression of target genes. Inhibitory 
SMADs (SMAD6 and SMAD7) bind to the receptors, and prevent the phosphorylation 
and signaling activity of pathway-dependent SMADs [44].  
A non-canonical intracellular signaling cascade through p38 MAP kinase can also be 
activated by TGF-β1 [45] (Figure 9). 
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Figure 9. TGF-β signaling pathway canonical (left) and non-canonical (right) 
 
 
TGF-β pathway is important in matrix regulation in health and disease, and an 
increased TGF-β activity is a key factor in the development of various forms of TAAs.  
The first indication of TGF-β1 being responsible for aneurysm pathogenesis came 
from the research field of monogenic forms of TAAs thanks to the discovery of the 
molecular mechanisms underlying MFS [46]. Fibrillin1, together with other 
extracellular matrix proteins, contributes to the sequestering of TGF-β1 by 
maintaining it in a bound and inactive state. Mutant versions of fibrillin1 are incapable 
of doing so and result in the abundantly accessible TGF-β1 to its receptors. Target 
genes of TGF-β1 such as metalloproteinase (MMP2 and MMP9) [47] contribute to 
matrix proteolysis which is the hallmark of TAA. Hence, the increased TGF-β1 activity 
explains the histological abnormalities observed in aortas of patients with MFS. This 
includes elastin fragmentation, vascular smooth muscle cells apoptosis as well as 
other associated-phenotypes, such as bone overgrowth and mitral valve anomalies 
[48]. Treatment of mutant mice with systemic TGF-β1 neutralizing antibodies reversed 
some of Marfan phenotypes [49].  
As already mentioned, Loeys–Dietz syndrome is another syndromic form of TAA 
caused by mutations in TGFBR1 and TGFBR2, resulting in aortic dissection and 
dilatation at early ages. Most mutations are missense mutations that commonly affect 
the intracellular kinase domain of the receptor, reducing receptor signaling activity in 
response to TGF-β1. Paradoxically, cells obtained from the aortic wall of patients with 
Loeys–Dietz syndrome had an increased TGF-β1 activity, highlighting the central role 
of increased and dysregulated TGF-β1 signaling in aneurysm formation [13]. The 
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hypothesis proposed to explain this paradox assumes that an alternative TGF-β1 
signaling pathway via direct stimulation of TGF-βR2 without TGF-βR1 could be 
activated. Moreover, the angiotensin II receptor, can initiate a rapid SMAD3-
phosphorylation in a TGF-β independent fashion [50, 51]. Cross talks among different 
signaling can account for SMADs phosphorylation despite TGF-β receptor 
insufficiency.  
 
 
1.6 EXTRACELLULAR MATRIX COMPONENTS IN THE AORTIC WALL: THE 
LOSS OF HOMEOSTASIS IN TAA PATIENTS  
 
Apart from serving as conduit for the blood originating from the left ventricle, the 
thoracic aorta performs several sophisticated functions. In fact, the ascending aorta 
allows the propagation of the pulse wave through the vasculature and ultimately 
influences the efficiency and distribution of blood flow.  
The propagation of the pulse wave depends on the structure of the thoracic aorta 
itself, which combines intrinsic contractile properties with the elastic recoiling 
capacity. The capacity to withstand the highest blood pressure in the vasculature 
resides in the structure of the thoracic aorta. To each ventricle ejection at systole, the 
thoracic aorta responds with a dilatation followed by a return to its initial diameter 
during diastole.   
All arterial walls have the same basic triple layer composition—intima, media and 
adventitia. These layers are separated from each other by two layers of thick elastic 
fibers, the internal and external elastic laminae. Depending on their location in the 
vascular tree, these layers vary considerably in thickness, composition and biological 
properties. 
The basic structural and functional unit in the aortic wall is the lamellar unit [52]. 
Each lamellar unit is composed of a vascular smooth muscle cell lying between two 
layers of elastin fibers and surrounded by extracellular matrix proteins containing 
microfibrils and proteoglycans. Lamellar units are intercalated by collagen bundles 
(Figure 10).   
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Figure 10. The lamellar unit 
Electron micrograph of a single lamellar unit in the medial layer of the aortic wall 
Permission obtained from [5]. 
 
The interaction and cross-talk between the vSMCs and extracellular matrix 
components in the aortic wall warrants the various functions of the aorta.  
 
During TAA formation the aortic wall homeostasis can be lost due to:  
- dysregulation of one or more of the important players (cells, collagen, elastin, 
microfibrills). 
- dysregulation of important regulatory pathways controlling the aortic wall 
normal function (tissue repair). 
 
1.6.1 Vascular SMCs  
The medial layer of the aorta is populated mainly by vSMCs, which are 
circumferentially aligned and interspaced by thin layers of elastic fibers. VSMCs are 
not terminally differentiated [53]: they possess both contractile and secretory 
properties and depending on the needs (homeostasis state) can alternate quiescent, 
contractile or proliferative states.  
The latter corresponds to the synthetic phenotype that comes into play when a 
repair of ECM components is required. The vSMCs synthetic properties depend on 
biochemical signals such as TGF-β1 stimulus. Moreover, vSMCs can transform 
mechanical stimuli into biological responses (also known as mechano-transduction) 
[54], leading to intracellular responses and extracellular changes (synthesis, alignment 
and repair of particular ECM components).  
VSMCs loss is a common hallmark of aneurysmal aortic wall independent of the 
types of TAAs. The importance of integrity of vSMC layer in aorta is manifested by the 
fact that two SMC specific gene mutations have been linked to the formation of 
familial non syndromic TAAs: ACTA2 and MYH11 encoding for a smooth muscle cell 
specific actin and a smooth muscle myosin heavy chain family, respectively. ACTA2 
mutations interfere with actin filament assembly and are predicted to decrease SMCs 
contraction [55]. MYH11 mutations are associated with marked aortic stiffness and 
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examination of pathological aortas in tissues bearing this mutation showed large areas 
of medial degeneration with very low vSMCs content [56].  
Interestingly, the embryological origin of SMCs along different region of the aorta is 
different, highlighting the differences between aortic pathologies in the thorax and 
abdomen. During the early stages of embryonic development, migration and 
differentiation of cells from the neural crest give rise to the ascending aorta, the aortic 
valve and the ductus arteriosus. The abdominal aorta, on the other hand, is mainly 
composed of cells derived from mesoderm (Figure 11). Differences in cell lineage 
result into different cellular responses to TGF-β. TGF-β1 stimulation of neural crest-
derived SMCs resulted in a significant increase in cell proliferation, activation collagen 
production whereas the stimulation of mesoderm-derived SMCs did not have the 
same effect [57]. The different embryonic origin combined with the structural 
differences between the thoracic and abdominal lamellar units, accounts for the 
regional heterogeneity within the aorta and the unique properties of the thoracic 
aorta as described earlier. 
 
 
Figure 11. Developmental origin of cells populating the ascending aorta. aAo: 
ascending aorta, dAo: descending aorta, INN: innominate artery, LCA: left carotid 
artery, LSCA: left subclavian artery, PT: pulmonary trunk, RCA: right carotid artery, 
RSCA: right subclavian artery. Permission obtained from [58]. 
 
 
1.6.2 Collagen 
Type I and type III collagen are the most abundant collagen fibers in the aortic wall 
[59]. They are present in the adventitia and media layer and provide tensile and 
mechanical strength to the aorta. Collagen also participates in the activation of 
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intracellular pathways by interacting with trans-membrane receptors on vSMCs as 
well as with other ECM proteins. Collagen fibers also act as reservoirs for soluble 
enzymes and cytokines in the ECM, thereby regulating their function (Figure 12). 
Mutations affecting the collagen fibers, such as the ones found in COL3A1 observed 
in type IV Ehler-Danlos syndrome, can influence both the structure and the function of 
the aortic wall.    
 
Figure 12. Roles of collagen fibers in the ECM. 
Permission obtained from [5]. 
 
 
Collagen has the vital role in maintaining the shape of aorta. Impairments of the 
collagen homeostasis, either affecting the quality or the quantity of the fibers, 
underlie the actual dilation and the ultimate mechanical failure of the vessel wall [60]. 
 
Collagen biosynthesis - α1 and α2 peptide chain synthesis is carried out on ribosomes 
located on the endoplasmic reticulum (ER) membrane. The nascent pre-pro-α-chains 
protrude after translation into the lumen of the rough ER with the help of signal 
recognition particles and receptors. After removal of the signal peptide, the 
procollagen α-chains undergo multiple post-translational modifications, including 
hydroxylation of specific proline and lysine residues, and glycosylation of 
hydroxylysine. The hydroxylation of lysine residues into hydroxylysines is catalyzed by 
different lysyl hydroxylases (LH or PLOD).  
After undergoing these post-translational modifications the pro- α-chains associate 
into a triple α-helix through disulfide bounds (formed by two alpha-1 chains and one 
alpha-2 chain). The α-triplehelix or procollagen is packaged within the Golgi 
compartment into secretory vesicles and transported outside the cell where is 
converted to collagen.  
The formation of intermolecular and/or intra-molecular cross-links is the final step 
in the biosynthesis of collagen, essential for physical and mechanical properties of 
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collagen fibrils as well as for its stabilization. Stabilization of collagen fibers is achieved 
by the formation of covalent cross-links between neighboring collagen molecules. The 
major type, hydroxylysyl pyridinoline (HP), is made of three hydroxylysines, and a less 
abundant form, lysyl pyridinoline (LP) consists of two hydroxylysines and one lysine 
(Figure 13). 
Hydroxylation of lysine residues is a fundamental step in the maturation of 
collagen, determining the chemical nature of intermolecular cross-links [61]. 
Depending on the lysine position in the triple helix, specific lysyl hydroxylases will 
perform the reaction. PLOD2 acts on lysine present in the telopeptide of the triple 
helix and the conversion into hydroxylysine is fundamental for the formation of cross-
linking in general (via generation of pyridinolines) [62]. On the contrary, PLOD1 acts on 
lysine residues located within the triple helix [63] thereby influencing the amount of 
hydroxylysine available which ultimately affects the relative amount of HP and LP. 
 
 
 Figure 13. Collagen cross-linking/fibril formation 
 
Mutations in PLOD1 have been shown to be the cause of the kyphoscoliotic type of 
Ehlers-Danlos syndrome (EDS VI-A) [63, 64], a syndrome associated with severe 
aortopathy including aneurysm and dissection. Plod1-/- mice have a decreased aortic 
HP/LP ratio and an increased risk of aortic rupture compared to the wild-type mice 
[65].  
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1.6.3 Elastin 
Elastin is the most abundant ECM protein in the aortic wall, constituting up to 50% of 
the dry weight of the thoracic aorta. In addition to the structural role, elastin has an 
active role in regulation of vSMCs in the media layer of the aortic wall through direct 
interaction with integrin receptors. Elastin modulates cytoskeletal actin organization 
and limit cell proliferation and migration [66]. In aneurysmal thoracic aortas elastin is 
fragmented but, in contrast to other ECM proteins, disruption of elastin does not 
result in aneurysm rupture. Instead, elastin abnormalities result in an uncontrolled 
proliferative state of vSMCs, which highlights the regulatory role of this protein on 
vSMCs homeostastis [67] (Figure 14). 
 
      Figure 14. Elastin fragmentation in TAA. 
        Permission obtained from [5]. 
 
 
1.6.4  Fibronectin 
Fibronectin (FN) is a ubiquitous ECM glycoprotein that is assembled into a fibrillar 
matrix in all tissues and throughout all stages of life. Its assembly is a cell-mediated 
process [68] and is essential for life [69]. Cells mediate FN matrix assembly through 
integrin binding to the RGD (Arg-Gly-Asp) cell-binding domain. The primary receptor 
for FN matrix assembly is α5β1 integrin. 
FN is a multi-modular protein and has domains for interacting with other ECM 
proteins, cell surface receptors, glycosaminoglycans, and other FN molecules. This 
combination of domains allows FN to bind simultaneously to cells and to molecules 
within the surrounding matrix (Figure 15).  
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Figure 15. Communication cell-ECM through fibronectin 
Permission obtained from Nature Education. 
 
FN is encoded by a ∼8-kb mRNA yielding FN subunits that range in size from 230–
270 kDa depending on alternative splicing. Two intra-molecular disulfide bonds form 
within each type I and type II module to stabilize the folded structure. Type III modules 
are seven-stranded β-barrel structures that lack disulfide bonds (Figure 16). 
 
 
 
Figure 16. Fibronectin modules. Permission obtained from [70] 
 
 
The exact composition of FN depends on the tissue type and/or cellular conditions. 
Alternative splicing occurs by exon skipping at EIIIA/EDA (Extra Domain A) and 
EIIIB/EDB (Extra Domain B) and by exon subdivision at region IIICS, producing more 
than 20 different isoforms in humans. 
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FN exists in two major forms, termed plasma FN and cellular FN. Cellular FN which 
is made by several cell types including endothelial cells, fibroblasts, smooth muscle 
cells, macrophages and chondrocytes, is deposited in the ECM as highly insoluble FN 
filaments. Plasma FN is produced by hepatocytes accounting for 1% serum protein. 
Cellular forms of FN differ from plasma FN for the inclusion of EDA and EDB domains 
[71]. In vivo studies with experimental animal embryos have shown that cellular forms 
of FN are expressed in development [72, 73].  
Cellular FNs are the only isoforms present during embryogenesis and exerts 
important role in developmental processes such as directing the migration of cardiac 
precursors anteriorly towards the midline to form a single heart tube. The heart tube 
undergoes right-ward looping to change from anterior/posterior polarity to left/right 
polarity. Proper positioning and function of the valves is critical for chamber formation 
and proper blood flow [74]. Once development is complete, the amount of insoluble 
cellular FNs decrease in a wide range of tissues [75] but it is up-regulated again during 
the pathogenesis of many disorders, including cancer and fibrosis [76-78]. The 
“embryonic” splicing pattern is temporally re-established in adult life also in 
physiological tissue repair and angiogenesis [73, 79].  
 
 
1.6.5 Tissue repair 
The tissue repair process is characterized by the appearance of activated 
myofibroblasts, a transient population of cells that have a phenotype in between 
fibroblasts and smooth muscle cells [80]. Myofibroblasts can derive from the loss of 
contractile phenotype (or acquisition of "synthetic phenotype") of a smooth muscle 
cell, differentiation of a progenitor resident cell in the stromal tissue, recruitment of 
mesenchymal precursors, or epithelial to mesenchymal transdifferentiation of 
epithelial cells. Myofibroblasts, by virtue of acquiring smooth muscle type actin-
myosin (α-SMA) complex (Figure 17), can contract the edges of the wound and speed 
up the wound repair, an event that is regulated by TGF-β1 [81].  
 
 
 
Figure 17. Myofibroblasts positive for α-SMA 
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Meanwhile, the production of ECM is heavily activated and the FN containing EDA 
exon is one of the most important activated proteins in this process. The promotion of 
EDA inclusion is influenced by TGF-β1 [82, 83] (Figure 18).  
TGF-β1, EDA-FN and myofibroblasts activation can all be contextualized in the 
thoracic aorta undergoing dilatation. Weakening of the aortic wall (depending on 
different TAA etiologies) results in ECM degradation. As a physiological response, 
tissue repair is triggered, driven by TGF-β that exerts its action by activating 
myofibroblasts, ultimately targeting fibronectin and its splicing variants to the 
damaged vascular tissue. 
 
 
 
 
Figure 18. TGF-β1 via increase of EDA-FN promotes the differentiation into mature 
myofibroblast. Permission obtained from [80]. 
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 2 AIMS OF THE STUDY 
 
The overall aim of this thesis was to characterize the molecular events underlying the 
differences in aneurysm development in BAV compared to TAV. 
 
Specific aims: 
 
- As the alternative spliced EDA-fibronectin is a crucial player in wound healing 
response, the aim of Paper I was to investigate the expression of EDA-
fibronectin with aneurysm development in BAV and TAV aortas. 
 
 
- Since the production of the EDA-fibronectin depends on TGFβ signaling, the 
aim of Paper II was to investigate if alternative splicing events occurring in 
TGFβ pathway could discriminate aneurysm development in BAV and TAV. 
 
 
- As TGFβ was pointed as a discriminator of BAV and TAV aneurysm and it is 
known to be dysregulated in monogenic form of TAA, the aim of paper IV was 
to investigate whether there are inherent differences between BAV and TAV 
cell response to TGFβ treatment. 
 
 
- Given the important role of collagen in providing strength to the aortic wall, 
the aim of paper III was to evaluate collagen synthesis and cross-linking in 
patients with BAV using normal TAV patients as a reference. 
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 3 COMMENTS ON METHODS 
 
This chapter refers to material and methods used during the work underlying this 
thesis. For further details, see the Materials and Methods section of Paper I-IV, 
respectively. 
 
 
3.1 PATIENTS  
 
All the paper presented in this thesis are based on the ASAP study (Advanced Study of 
Aortic Pathology) [84]. 
ASAP is a prospective study enrolling a total of 600 consecutive patients 
undergoing elective surgery due to aortic valve disease and/or ascending aortic 
aneurysm at the Cardiothoracic Surgery Unit at Karolinska University Hospital. 
Exclusion criteria included indications for other concomitant valve surgery, presence 
of significant coronary artery disease and/or previous cardiac surgery. This study was 
approved by the Ethics Committee at the Karolinska Institutet and patients were 
included after informed, written and signed consent.  
The ascending aorta was considered to be non-dilated at a diameter of 4.0 cm or 
less and dilated at a diameter of 4.5 cm or more [85]. Subjects with aortic dimensions 
of 4.1 to 4.4 cm were not included in the studies. Aortic biopsies were taken from the 
anterior (convex) part of the aorta i.e. the site of aortotomy a few cm above the aortic 
valve.  
All patients were operated on through a midline sternotomy using cardio-
pulmonary bypass and cardiac arrest. For isolated aortic valve replacement a 
biological or a mechanical valve prosthesis was used. Patients with only dilatation of 
the ascending aorta received a single tubular graft prosthesis while patients with 
combined valve and ascending aortic pathology were operated on using a valve 
prosthesis combined with a supracoronary graft or alternatively a mechanical or a 
biological composite graft. 
 
 
3.2 RNA AND PROTEIN ANALYSES 
 
The intima-medial layer of the aortic specimens was isolated by adventicectomy [86]. 
RNA and proteins were extracted from the intima-media fraction for expression 
analysis purposes. The RNA samples were hybridized and scanned at the Karolinska 
Institute microarray core facility.  
Gene arrays are powerful tools that allow to measure expression of thousands of 
genes from a single sample. We chose to use the Affymetrix GeneChip® Human Exon 
1.0 ST array, a special type of array that enables two complementary levels of analysis: 
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gene expression and alternative splicing (Figure 19). In fact, it is designed to cover 
each exon of the human genome with approximately four probes per exon and 
roughly 40 probes per gene. The "gene-level" expression analysis implies that the 
multiple probes on different exons are summarized into an expression value of all 
transcripts from the same gene.   
 
 
Figure 19. Exon array design 
(from www.bcm.edu)  
 
The "exon-level" analysis whole-genome scale was especially relevant in paper II, 
where we investigated the splicing of 26 selected genes belonging to the TGF-β 
pathway. The expression level of each of the 614 exons (all the exons accounting for 
the 26 genes) was normalized with respect to whole transcript (gene) expression 
(splice index). 
 
Splice Index = log2 (exon intensity/transcript expression level) 
 
In parallel to RNA expression profiling studies, the aortic media biopsies were also 
used for validation at the protein level. Tissues were freshly dissected, homogenized 
to obtain protein lysates and western blot analysis and immunohistochemistry were 
performed. 
 
 
3.3 STATISTICAL ANALYSES 
 
When dealing with microarray data it is important to correct for random events that 
falsely appear significant. In a typical microarray experiment sometime, more than 
10,000 separate hypotheses are tested. If a standard p-value cut-off of 0.05 is used, 
500 genes would be falsely believed “significant” by chance. Therefore the importance 
of setting a multiple testing correction is pivotal. In all papers paired and unpaired 
Student’s T-tests were used and the significant p-values for each comparison were 
adjusted by applying the Benjamini and Hochberg False Discovery Rate method.  
In paper I the gene set enrichment analysis was performed comparing TAV and BAV 
patients. This algorithm tests if a particular group of genes show more differential 
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expression than it could be expected from a randomly selected group of genes of the 
same size [87].  
In order to understand the attributes of the 217 genes found in paper IV a gene 
ontology analysis was done. This allowed us to gain a broad overview of our gene set 
and find out which gene ontology categories are ‘enriched’ for our 217 genes. 
In paper I, II and IV the TGF-β signaling pathway was investigated by the usage of a 
multivariate analysis (MVA) approach, a statistical technique used to analyze data that 
arise from more than one variable. The screening of several patients with regard to 
gene/exon level expression generates multidimensional data. Each patient will thus 
have a unique expression profile that is a summary of all the genes/exons present in 
the data set, an expression fingerprint for that particular patient. Patients that show 
similar profiles to each other will group together in the MVA plot. 
For example in paper II and IV each patient could be positioned in a 
multidimensional space by the expression of genes involved in the TGF-β signaling 
pathway. With MVA it is possible to consider all the variables simultaneously and 
observe the existing inter-dependency among them. Two tools are used in MVA: 
Principal component analysis (PCA) and orthogonal partial least squared projection to 
latent structure discriminant analysis (OPLS-DA). PCA is a mathematical algorithm that 
can reduce the dimensionality of the data while keeping most of the variation in the 
data set.  
In our study, for each patient we had more than 10,000 dimensional gene 
expression profiles which were projected onto the principal components. Along PC1 
the variation in the data is maximal. The second principal component (pc2), 
perpendicular to pc1, accounts for the second largest variation in the data and results 
into a two-dimensional plot (Figure 20 a). By adding a third principal component we 
further increase the capability of the PCA model to describe the variation unexplained 
by the two previous components and eventually better detect interdependency 
among variables that can result in clustering of the sample (Figure 20 b). 
  
 
 
Figure 20 a. Projection of multiple variables into pc1 and pc2 
(from www.umetrics.com) 
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Figure 20 b. 3D PCA, each dot represents a patient and its position in the 3D space depends on 
the gene expression profile measured by the exon array platform. 
 
 
PCA is useful to get an overview of a dataset and was chosen to visualize graphically 
the distribution and clustering of the ASAP patients with BAV or TAV, based on the 
expression profile of selected genes. Additionally, with OPLS-DA it is possible to 
analyze together the quantitative relationship between a data matrix X, in our case 
expression levels of different 614 exons belonging to TGF-β pathway, and a vector (or 
matrix), Y, containing qualitative values (class belonging to BAV or TAV phenotype). 
The main idea of OPLS-DA is to separate the systematic variation in X into two parts, 
one that is linearly related to Y and one that is unrelated (orthogonal) to Y. In this way 
it is possible to remove systematic variation from X that is not correlated to the 
response set Y, thereby giving the opportunity to study only the variation that is 
correlated to the classification of interest. It is also termed as supervised analysis since 
it implies the assignment to a certain group, in our case being for example a BAV or a 
TAV based on medical records.  
 
 
3.4 CELL ISOLATION  
 
Human aortic SMCs were isolated from TAV and BAV aortic biopsies. Depending on 
the size of the biopsy, AoSMCs were either obtained by enzymatic digestion or by 
explant outgrowth technique [88].  
The enzymatic method was used in case of dilated aorta biopsies (Figure 21): the 
cells preparation consisted of an immediate dissection to separate medial and 
adventitial layers followed by enzymatic digestion. Medial samples were incubated in 
a collagenase 0.3% solution for 2 hours at 37°C under shaking, to obtain SMC cultures. 
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Figure 21. Dilatation of the ascending aorta 
 
In the case of non-dilated aortas, small biopsies were available and the explant 
technique was the method of preference (Figure 22). The media was firstly separated 
from adventitia layer and then kept in culture wells with specific medium for 
approximately 10 days, time necessary in order to detect SMCs outgrowth from the 
tissue.  
 
   
Figure 22. Explant outgrowth 
 
In paper IV valves biopsies were also used for the isolation of myofibroblasts. The 
enzymatic method was preferred in this case. The valves could be stenotic (with 
different amount of calcium deposits) or regurgitant (very thin leaflets) (Figure 23). To 
facilitate the digestion process of the stenotic valves the hard and calcified deposits 
were removed.  
Cells, either AoSMCs or myofibroblasts were held in culture and treated between 
passages 3 to 6 with TGF-β1 for 6 hours in serum free medium to avoid any interaction 
of TGF-β1 with the medium growth factors. 
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Figure 23. Appearance of removed stenotic (left) and regurgitant valve (right) 
 
 
3.5 COLLAGEN ANALYSES 
 
In paper III the amount of collagen and its cross-linking forms was measured by High-
performance liquid chromatography (HPLC) a technique used to separate a mixture of 
compounds. The separation of the sample mixture occurs through the interaction with 
the column particles and spectrophotometric techniques are used to measure the 
concentration after the elution. After deparaffinization in xylene of 10-μm slices of 
paraffin-embedded tissue, the samples were hydrolyzed in 1 mL 6 M HCl in 5-mL 
Teflon sealed glass tubes and then dried and re-dissolved in 1 mL of water containing 
10 μmol/L of pyridoxine (internal standard for the cross-links HP and LP) and 2.4 
mmol/L of homoarginine (internal standard for amino acids). Derivatization of the 
amino acids with 9-fluorenylmethyl chloroformate and reversed-phase HPLC of amino 
acids and crosslinks was performed on a reversed-phase column (150mm×4.6 mm) 
[89, 90]. The content of collagen, pentosidine (marker for collagen half-life), proline, 
hydroxyproline, hydroxylysyl, HP and LP (mature collagen cross-linking forms) were 
measured. Collagen cross-links with fluorescent properties are derived from two 
different pathways: those initiated by enzymes such as lysyl hydroxylase and lysyl 
oxidase (HP and LP) and those derived from the non-enzymatic glycation 
(pentosidine). The crosslinks were optimally detected by their native fluorescence by 
switching wavelengths of the detector during the assay. The quantities of the cross-
link HP were expressed as the number of residues per collagen molecule, assuming 
300 hydroxyproline residues per triple helix. This procedure is well established, 
because hydroxyproline is a collagen-specific amino acid and because the prolyl 
hydroxylation level in collagen is stable [91]. Amino acids, including the collagen-
specific hydroxylysine, hydroxyproline and the glycosylated hydroxylysines were 
eluted with a multistep gradient system and were separated in less than 30 min, 
followed by reaction with ninhydrin and fluorimetric detection [92].  
Picrosirius red staining was used for the assessment of collagen fibers in aortas: 
thick mature, tightly packed, and better-aligned collagen fibers were orange, and thin 
immature fibers were green. To further investigate the collagen structure in the 
aortas, we performed both scanning electron microscopy (SEM) that provides high-
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resolution, three-dimensional images of the extracellular matrix morphology and 
transmission electron microscopy (TEM) for a closer observation of the collagen 
filaments size. For SEM, aortic biopsy samples were fixed, rinsed in distilled water and 
placed in ethanol followed by pure acetone. After drying, specimens were mounted 
on an aluminum stub and coated with carbon before the analysis at SEM. For TEM, 
aortic tissues were fixed by immersion in 2% glutaraldehyde and 1% 
paraformaldehyde and post-fixed in 2% osmium tetroxide. Semi-thin sections were 
prior stained with toluidine blue and used for light microscopic analysis in order to 
select areas of the media layer for closer analysis. From those areas ultra-thin sections 
(40 to 50 nm) were cut, contrasted with uranyl acetate followed by lead citrate, and 
examined in a transmission electron microscope. 
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 4 RESULTS AND DISCUSSION 
 
This chapter highlights the main findings of each paper. For a more detailed 
description of the results, see the Result section in Paper I-IV, respectively. 
 
 
4.1 IMPAIRED SPLICING OF FIBRONECTIN IS ASSOCIATED WITH TAA 
FORMATION IN PATIENT WITH BAV 
 
Loss of smooth muscle cells and degeneration of extracellular matrix are the main 
outcomes of an aneurysm developing in the ascending aorta. Fibronectin plays a 
crucial role in the maintenance of the extracellular matrix homeostasis [69]. 
Alternatively spliced extra domain A of fibronectin appears to be important for cell 
migration and proliferation, mechanisms that are central for normal functions such as 
tissue repair and maintenance of tissue integrity and therefore may be involved in 
aneurysm formation and progression.  
Since TAA is a common complication in patients with BAV, in paper I, we analyzed 
the expression of EDA-fibronectin in dilated and non-dilated ascending aorta of TAV 
and BAV patients. Microarray data from a total of 109 patients revealed that EDA-FN 
expression was significantly higher in dilated aorta of TAV compared to BAV patients, 
a result that was confirmed also at the protein level (Figure 24-25). 
 
 
 
Figure 24. EDA exon expression is higher in dilated TAV compared to non-dilated but remains 
unchanged in BAV. Real-time PCR was used to measure the ratio between FN containing EDA 
and total FN forms and highlighted the significantly higher presence of EDA-FN isoform in TAV 
dilated compared to BAV. 
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Figure 25. Staining of EDA containing FN in non-dilated (<40mm) and dilated (>45mm) aortic 
sections. The staining of EDA containing FN was much more pronounced in dilated aorta from 
TAV patients compared with dilated aorta from BAV patients. Total FN staining showed no 
different expression in TAV dilated compared to non-dilated.  
 
EDA-FN is normally not expressed in adulthood, unless as a response to some 
triggering factors, for instance to tissue damage [73]. As expected, we found that the 
major isoform in the aortic tissue was the FN without EDA. However, EDA-FN isoform 
could also be detected, exclusively in TAV patients. In particular we observed a higher 
presence of EDA-FN in association with the dilatation in the aorta (Figure 26).  
 
 
 
Figure 26. RT-PCR was performed with primers spanning EDA exon. The main isoform (lower 
band) does not include EDA exon. EDA-FN (upper band) is only present in TAV aortas, with 
higher intensity in dilatation. 
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Inclusion of EDA exon is promoted by TGF-β treatment [82, 83]. Defects in the TGF-β 
signaling pathway has attracted attention in the field of TAA as the cause of the aortic 
wall degeneration that leads to aneurysm. Therefore we investigated the effect of 
TGF-β signaling in vSMCs isolated from BAV and TAV aortas as a possible cause of the 
different FN splicing observed in the tissue. We found that only TAV cells respond to 
TGF-β1 treatment by stimulating the inclusion of EDA exon (Figure 27). 
 
 
 
 
 
 
 
 
 
Figure 27. TGF-β1 stimulation influence positively the inclusion of EDA only in vSMCs isolated 
from TAV aorta. The main isoform in culture is the EDA-FN (upper band). (Real-Time PCR on 
the left and RT-PCR analysis on the right) 
 
 
A possible explanation is that TGF-β treatment can trigger different cascades in BAV 
and TAV cells (Figure 28) resulting in a deficiency of BAV cells to perform “exon 
inclusion” splicing mechanism. Using the gene-set enrichment (GAGE) algorithm we 
examined whether the expression of TGF-β pathway related genes on average 
differed more than what was expected for the same number of randomly selected 
genes between BAV and TAV patients. This analysis revealed that TGF-β genes on 
average showed more significant differences between BAV and TAV than genes in 
general. The significant differences were detected only in dilated aortas (GAGE 
probability values = 0.0248).  
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Figure 28. Volcano plot of the TGF-β pathway in BAV and TAV patients. Fold change between 
the 2 groups is shown on the x-axis, and the probability value for a t test of differences 
between samples is shown on the y-axis. 
 
To conclude, in paper I we demonstrated that BAV patients have impaired mechanism 
for the inclusion of EDA in response to injury such as aneurysm formation, which is a 
possible explanation for their increased TAA susceptibility. The defect in FN splicing 
signifies impairments of the TGF-β signaling pathway. 
 
 
 
4.2 DIVERGING ALTERNATIVE SPLICING FINGERPRINTS IN TGFΒ 
SIGNALING PATHWAY IDENTIFIED IN TAA 
 
As a follow up of paper I, we pursued with TGF-β signaling pathway and investigated 
the alternative splicing phenomenon within the main players of the TGF-β cascade. 
Differential splicing is a common phenomenon that can influence the function of 
proteins and thus being an important process in human diseases. In paper II we have 
investigated the occurrence of differential splicing in the TGF-β pathway associated 
with TAA in patients with BAV and TAV. Exon array data from 81 patients, 51 dilated 
(15 TAV, 36 BAV) and 30 non-dilated (14 TAV, 16 BAV) were utilized in this study. All 
known exons of TGF-β pathway related genes were subjected to alternative splicing 
analysis.  
For this purpose a comprehensive gene-list consisted of all the important players in 
TGF-β pathway, including fibronectin, was created. This list contains 26 genes which 
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correspond to 614 exons. Importantly, the expression of each exon was normalized to 
the expression of the entire transcript by calculating the splice index. In order to 
identify differentially spliced TGF-β exons and their potential contribution to dilated 
aorta in patients with TAV and BAV, multivariate data techniques such as PCA and 
OPLS-DA were adopted together with FDR corrected two-sided Student’s T-test. 
By applying PCA based on the splice index of the “614 TGF-β exons”, we showed 
that it was possible to discriminate the dilated and non-dilated aorta in BAV and TAV 
patients (Figure 29).  
 
 
 a  b 
 
Figure 29. Three-dimensional scores plot showing PC1-PC3 plane of non-dilated (black) and 
dilated (red) thoracic aorta samples with TAV (a) and BAV (b) patients separately. 
  
The first conclusion drawn from this analysis was that alternative splicing is an 
important mechanism in aneurysm development, both in BAV and TAV patients. To 
find out which exons were responsible for separation and therefore were important 
for the dilatation process, we used FDR-corrected t tests between dilated and non-
dilated aortas. When this method was applied to TAV patients, 147 exons showed 
significant differences in splicing, with a cutoff P value of 0.023. The corresponding 
analysis for BAV patients resulted in 101 significant exons with a cutoff P value of 
0.013. The results were applied to a Venn diagram which showed that among the 
significant exons 86 were TAV and 40 were BAV differentially spliced, respectively 
(Figure 30).  
Apart from discovering that alternative splicing pattern in the TGFβ pathway is 
different between dilated and non-dilated aortas, this statistical analysis showed that 
diverging alternative splicing fingerprints are associated with dilatation in TAV and 
BAV patients. 
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Figure 30. Venn diagram based on FDR corrected t-test:                                                                                                                 
TAV specific (blue), BAV specific (green), and common (red) exons. 
 
Furthermore, OPLS discriminant analysis was used to extract the contribution to the 
model (difference between dilated and non-dilated) of the most significant exons, 
information that is demonstrated by the loading plot (for BAV and TAV), as shown 
below (Figure 31).  
 
 
Figure 31. Loadings for TAV model versus BAV model. Significant exons (FDR corrected t-test) 
in TAV only (blue), BAV only (green) and shared (red) are far from the origo. Non-significant 
exons are marked in grey. 
 
 
In accordance with paper I findings, EDA exon of FN, appeared as one of the highest 
exon responsible for the separation between non-dilated and dilated TAV patients and 
was validated with RT-PCR on RNA extracted from aortic biopsies (Figure 32-33). 
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Figure 32. PCA of non-dilated (black) and dilated (red) TAV (left). Bar plot for the loadings of 
each of the significant exons indicating their contribution to the first PC (Pc1): EDA exon is 
highlighted. 
 
 
 
 
Figure 33. RT-PCR validation of alternative splicing of FN1_EDA. 
 
Conclusions of paper II imply that the dilatation in the two different valve types 
proceeds via different alternative splicing mechanisms in the TGF-β pathway. The 
splicing of EDA exon of FN which was observed only in TAV dilated aortas (exon-
inclusion) can therefore depend on specific TGF-β pathway splicing pattern (Figure 
34). 
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Figure 34. Simplification of the two alternative splicing fingerprints of BAV and TAV resulting in 
EDA exon inclusion. 
 
 
 
4.3 IMPAIRED COLLAGEN BIOSYNTHESIS AND CROSS-LINKING IN AORTA 
OF PATIENTS WITH BAV 
 
In paper III, we investigated the ECM constituting the aortic wall in BAV and TAV aortic 
specimens with a particular focus on collagen, the crucial player endowing aorta with 
strength and resistance.  
Masson trichrome staining and high-performance liquid chromatography (HPLC)-
based measurements showed that there was a significant increase of collagen in the 
dilated aortas of TAV (Figure 35). This was interpreted as a response of the TAV aorta 
to aneurysm formation in an attempt to compensate for ECM degeneration, hallmark 
of dilatation process.  
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Figure 35. Masson trichrome staining of dilated and non-dilated aortas from patients with BAV 
and TAV 
 
Moreover, further analysis demonstrated that this collagen is probably newly 
synthesized, as suggested by the small diameter of the collagen fibers measured by 
electron microscopy (Figure 36).  
 
 
Figure 36. Thin collagen fibers in dilated aorta of TAV patients:  
scansion (left) and transmission (right) electron microscopy. 
 
Interestingly, comparisons between non-dilated and dilated aortas of BAV patients 
showed no substantial difference in the amount of collagen. In addition, when 
analyzing the structure of non-dilated aortas, we found that in BAV patients compared 
to TAV, the collagen fibers are less mature as a consequence of a higher collagen 
turnover. The extent of collagen turnover was assessed by HPLC-based measurement 
of pentosidine, a marker of non-enzymatic collagen glycation [93]. In fact, under 
normoglycemic conditions, collagen glycation, a process that contributes to the 
maturation of the fibers, is largely determined by the half-life of collagen: if the 
collagen turnover is high (i.e. continuous proteolysis and new production), the 
chances to undergo glycation modifications  are little and this will be reflected by a 
low relative level of pentosidine (Figure 37). The fact that BAV non-dilated aortas have 
less mature fibers was also observed by Picosirius red staining (Figure 37) that allows 
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distinguishing thick, mature and tightly packed collagen fibers (staining in orange-red 
at the polarized light) from thin and immature fibers (staining in green).  
 
 
 
Figure 37: Pentosidine measurement (left, colored pink) and Picosirius red staining (right) of 
BAV and TAV non-dilated aortas. 
 
 
In this study we also further defined the types of mature collagen fibers. During 
collagen maturation, apart from early glycation events, a long series of post 
translational enzymatic modifications are necessary in order to obtain mature fibers. 
Cross-link reactions occur between the different collagen chains and eventually 
terminate with the formation of hydroxylysylpyridinoline (HP) and lysylpyridinoline 
(LP) [61].  
The ratio of HP/LP was found lower in dilated aortas from patients with BAV 
compared to TAV, indicating that BAV is associated with a defect in post-translational 
collagen modification. We could explain this by a deficiency of PLOD1 enzyme (the 
lysyl hydoxylase responsible for HP formation), found in BAV aortas (Figure 38).  
 
 
a   b 
 
Figure 38. a) HP/LP ratio measurement. b) Western Blotting with antibody recognizing PLOD1. 
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The HP/LP ratio is believed to be 8:1 in the human aorta [94], while it decreases in the 
bone due to higher concentration of LP (LP/HP is 0.3:1) [95]. The higher content of LP 
in BAV compared to TAV, could explain the increased aortic stiffness previously 
reported in children with bicuspid aortic valves [96].  This will contribute to a reduced 
elasticity and may explain the increased aortic aneurysm formation in BAV patients.  
From our results we could evince that during the dilatation process in BAV aortas, 
the collagen is not efficiently produced, both due to the lower synthesis/turnover as 
well as to impaired post-translational modification. 
 
 
 
4.4 INCREASED AORTIC TGFΒ SIGNALING IN PATIENTS WITH BAV 
 
In paper I and II we demonstrated that impairments in TGF-β signaling are associated 
to aneurysm development in patients with BAV. In project IV we further pursued the 
attempt to characterize a BAV-TGFβ signaling and therefore focused on the response 
of AoSMCs isolated from TAV and BAV aortas to TGF-β1.  
We found that BAV AoSMCs responded to TGF-β1 treatment by provoking a 
change in the expression of 217 genes. On the contrary, TGF-β1 treatment of TAV cells 
did not affect any significant change in gene expression. The changes resulted in both 
up and down-regulation (Figure 39).  
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Figure 39. a) 2-dimentional plot showing differentially expressed genes in BAV and TAV from 
paired t-test comparison (from un-treated to treated). The line outlines cut off after FDR 
correction. b) Volcano plots for the 217 differentially expressed genes in AoSMCs derived from 
BAV patients after TGF-β1 treatment. Dots to the left represent significantly down-regulated 
genes after TGF-β1 treatment and dots to the right represent significantly up-regulated genes. 
 
Gene ontology analysis specifically applied to the down-regulated genes revealed 
enrichment in pathways related to: positive regulation of angiogenesis, cell-cell and 
cell substrate adhesion, focal adhesions, cell migration and cytoskeleton, and cell 
proliferation. These pathways are all involved in wound healing repair processes [97], 
and the fact that they are down-regulated in response to TGF-β1 in BAV cells can be 
interpreted as defective signaling of this pathway in the repair process.  
To further investigate the relevance of the in vitro AoSMC culture system for the in 
vivo aorta of the patients, we analyzed the differential expression of the 217 genes 
identified in the cells, in the ASAP database. Principal component analysis showed 
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that, aneurysmal aortas from BAV and TAV patients could be separated in two clusters 
by considering the expression levels of the 217 genes (Figure 40). Thus, the finding in 
our in vitro system (217 targeted genes) could be validated in vivo and further 
strengthened the hypothesis that an impaired TGF-β1 response may explain the 
higher propensity of BAV to aneurysm development compared to TAV patients. 
 
 
 
Figure 40. PCA based on the expression of 217 TGFβ-regulated genes in the intima/media 
layer of dilated ascending aorta. Green dots represent patients with BAV and black dots 
represent patients with TAV. 
 
 
The TGF-β1-BAV effect on the 217 genes most likely depends on the intracellular 
cascade. We therefore analyzed the differential expression of intracellular TGF-β1 
cascade in BAV and TAV aortas (Figure 41). Interestingly, already before dilatation, 
TGBR1 expression was significantly higher in BAV aortas comparing to TAV (Figure 42). 
Moreover, the expression of SMAD7, an inhibitory SMAD protein [98], and TGFBR3, a 
potential negative regulator of TGF-β signaling were also lower in non-dilated BAV 
compared to TAV. These comparisons collectively suggested that the TGF-β signaling is 
higher in BAV as compared to TAV patients. 
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Figure 41. Volcano plots for the expression of 75 genes involved in the intracellular TGF-β 
signaling pathway in intima/media layer of non-dilated ascending aorta. 
 
 
 
 
Figure 42. Immunohistochemistry staining of TGBR1 in non-dilated aortas from BAV (right) and 
TAV (left) 
 
 
To test whether the BAV-specific response to TGF-β is genetically determined and 
could be observed in other cell types we analyzed the differential expression of the 
217 genes induced by TGF-β1 in fibroblasts isolated from the aortic valves of BAV and 
TAV patients and we found no specific effect in BAV fibroblasts, an indication that the 
differential response of BAV patients to TGF-β is aorta-specific (Figure 43). This was an 
important finding that led us to speculate that local epigenetic alteration in cells 
isolated from aorta may play a role in enhanced susceptibility of BAV to aneurysm. 
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Figure 43. Two-dimentional plot showing the expression of 217 genes in fibroblasts: almost all 
of the genes (202) are significantly changed from control to treatment in both BAV and TAV 
valve cells. 
 
 
 
 
In conclusion, BAV and TAV AoSMCs differed in TGF-β1 response, with cells isolated 
from BAV being more responsive than TAV. The 217 BAV-TGFβ target genes identified 
in cells were important in discriminating BAV and TAV aneurysmal aortas. Also, the 
expression of genes belonging to intracellular TGF-β cascade, such as TGFBR1, differed 
in non-dilated aorta of BAV patients (Figure 44). These results provide further support 
for the hypothesis that defective TGF-β signaling may underlie the higher fragility of 
aorta in BAV. 
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Figure 44. Translational model: form in vitro to in vivo 
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46 
 5 GENERAL DISCUSSION AND CONCLUSIONS 
 
Individuals carrying BAV have higher risk than general population to develop a TAA. 
Studies presented in this thesis highlight some possible reasons for the increased 
susceptibility of BAV to form aneurysm. 
During aneurysm formation the homeostasis status of the aortic wall is slowly lost: 
SMCs goes through apoptosis and ECM becomes extensively degraded, resulting in 
the loss of aortic structure and eventual enlargement into a pathological aneurysm. 
Tissue repair mechanisms start up by some specialized cells being recruited to the 
damaged area to repair the damage caused by the dilatation process. These cells are 
the myofibroblasts, contractile cells deriving from the resident and/or circulating 
progenitors cells [99, 100]. A possible source of the myofibroblasts, in the case of 
aortic wall, may be either fibroblasts located in the adventitia layer or the smooth 
muscle cells in the media layer (Figure 45).  
 
 
Figure 45. Origin of myofibroblasts in the aortic wall. Permission obtained from [101] 
 
VSMCs have in their innate genetic program the capacity to shift from contractile to 
synthetic phenotype [102]. The latter can possibly lead to the proto-myofibroblast 
stage: these cells have secretory properties, high proliferation rate and have lost the 
capacity to express smooth muscle α-actin [103]. Proto-myofybroblasts and synthetic 
vSMCs are very similar cells and are not easily distinguishable. However it is the proto-
myofibroblast that has the capability to develop into myofobroblast (the actual 
repairing cell) and this event is driven by TGFβ-1. Therefore, in principle, the task of 
repairing the damage in the media may be performed by a specific subtype of vSMCs, 
i.e. the subtype that after shifting to synthetic phenotype can become proto-
myofibroblast first and eventually myofibroblasts where smooth muscle α-actin is re-
expressed (Figure 46).  
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Figure 46. Myofibroblast activation from SMC. 
 
 
The expression of ACTA2, the gene encoding for smooth muscle α-actin, is known to 
be dependent on TGF-β1 via RhoA signaling pathway [104]. ACTA2 expression is 
increased in different types of TAAs, suggesting an activation of myofibroblasts which 
means that within the dilated aortic wall there is a certain attempt to compensate for 
ECM degradation. TGF-β, by activating myofibroblasts in the context of wound 
healing, also promotes the expression of EDA-fibronectin, an alternatively spliced form 
of fibronectin, with higher capacity of mediating cell-matrix-cell interactions [105]. In 
the aorta of normal tricuspid aortic valve undergoing dilatation, we have found signs 
of tissue repair process activation: vSMCs switch to myofribroblasts and become 
capable of activating the production of EDA-fibronectin. On the contrary, the aortas of 
BAV individuals were less efficient in producing EDA-fibronectin and this may well be 
explained by the differences in regulation of TGF-β cascade between BAV and TAV 
patients.  
Histological examinations of aortas from MFS and BAV patients have shown area of 
cystic medial necrosis without a change in inflammatory signals, compared to the 
control aortas [106]. In BAV aortas apoptosis may initiate the wound healing 
response, but this process cannot be properly completed due to the defective 
function of the relevant pathways. In support to this hypothesis, our group showed 
that inflammation related genes were up regulated in aneurysm development in TAV, 
but not in BAV patients [107]. This observation could be interpreted as aneurysm 
development in TAV is associated with inflammation. As inflammation plays a role in 
activating tissue repair mechanisms, the down regulation of inflammatory genes in 
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BAV aneurysmal aortas could be the outcome of a reduced wound healing mechanism 
in BAV patients. Irrespective of the underlying mechanisms, the conclusions drawn 
from these studies highlight the fact that BAV-TAA and TAV-TAA are two different 
diseases. Importantly, in paper III we showed that the aneurysmal aorta of TAV 
patients is characterized by a remarkable increase of collagen production, which 
indicates that a fibrotic event is going on to compensate for the dilatation process and 
strengthen the aorta. The absence of detectable fibrosis in BAV aortas indicated that 
the reparative mechanisms are not activated in BAV. Myofibroblasts are the cells 
responsible for inducing fibrosis [100] (Figure 47). Interestingly, CEBPB, a gene 
recently reported to be involved in pulmonary fibrosis [108] was down regulated in 
BAV aortas compared to TAV [107, 109]. 
As myofibroblasts (derived from resident vSMCs) are activated by TGF-β to induce 
fibrosis and collagen and EDA-fibronectin are targets of TGF-β signaling pathway, the 
reason for the absence of aneurysm-associated fibrosis in BAV could depend on 
impairments in the TGF-β cascade in BAV aortas.  
 
 
 
      Figure 47. Fibrosis process in the context of wound healing repair. 
(from www.invitrogen.com) 
 
 
TGF-β is still the pathway that attracts the highest interest in the field of TAA. The 
causative link between defective TGF-β signaling and monogenic forms of TAAs 
(Marfan syndrome, Loyes-Dietz disease) has been well established. Therefore, the 
investigation of the role of this pathway in non syndromic TAA patients has been given 
a high priority in this thesis. Paper II was devoted to study the differences in the 
splicing pattern of genes composing the TGF-β signaling cascade between BAV and 
TAV patients. When we analyzed the exons constituting the genes belonging to TGF-β 
pathway we found that BAV and TAV had a different sets of alternatively spliced 
exons, which can be interpreted into two different signaling pathways associated with 
the dilatation, one with a specific set of exons for BAV and one with different set of 
exons for TAV. Moreover, we found that cells directly isolated from BAV responded 
massively when treated with TGF-β which would categorize BAV-aneurysms 
somewhere closer to the monogenic form of TAAs. However the absence of this 
response in fibroblasts isolated from BAV aortic valves implies that TGF-β response is 
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aorta specific and may be due to the local epigenetic alteration of vSMCs in BAV. 
Specifically, the exclusive hyper-activation of BAV vSMCs cells exposed to TGF-β 
resulted in down-regulation of genes involved in angiogenesis and focal adhesion 
formation, which is in line with the model proposed by Maleki et al (AORTA, in press), 
where the balance and fine-tuning of TGF-β, between the pro and anti angiogenic 
processes may be disturbed in BAV. As angiogenesis is part of the wound healing 
response, the findings in paper IV well fit with this model. However there are still 
several undiscovered issues regarding the initiation of dilatation process in both BAV 
and TAV. Genetic predisposition can be a contributing factor to aneurysm in both BAV 
and TAV. In TAV senescence and inflammatory processes may enhance aneurysm 
formation. In BAV an epigenetic factor such as disturbed flow caused by abnormal 
valve geometry may facilitate the process of aortic wall weakening and destruction. 
Our observation that the specific response to TGF-β1 is particular for the cells isolated 
from aorta and not the valves gives support to the importance of an epigenetic factor 
such as the flow in individuals carrying a BAV. Chronic exposure to the disturbed flow 
may cause epigenetic changes with the outcome of an imbalanced and deregulated 
TGF-β1 response in BAV cells. 
In summary, differences in the TGF-β signaling can explain the increased aneurysm 
susceptibility of BAV. In our view, in patients with TAV, where a proper tissue repair 
response is active, the TGF-β pathway is specifically regulated and directed towards 
EDA-fibronectin and collagen production during aneurysm formation. In contrast, 
patients with BAV have an over activated TGF-β signaling both before and during 
aneurysm formation. The impaired TGF-β signaling in BAV patients may compromise 
the aortic wall homeostasis thus leading to increased risk for these patients to develop 
aneurysm (Figure 48). 
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Figure 48. BAV aorta is an aneurysm prone vessel. 
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